NOBU ANNOUNCES RESTAURANT AND RESIDENCES IN BELLEVUE, WASHINGTON
Press Release

NOBU ANNOUNCES RESTAURANT AND RESIDENCES IN BELLEVUE, WASHINGTON

Two luxury residential towers in Downtown Bellevue will be reimagined under the brand alongside a future Nobu restaurant and hospitality-driven lifestyle experience. NEW YORK, May 27, 2026 /PRNewswire/ — Nobu, the globally recognized luxury lifestyle brand, is pleased to announce its arrival in Bellevue, Washington through the rebranding of two luxury residential towers as Nobu […]

Read More
SynuSight-Shanghai Jiao Tong University Collaboration Published in Cell, Advancing Diagnostic Classification of Synucleinopathies
Press Release

SynuSight-Shanghai Jiao Tong University Collaboration Published in Cell, Advancing Diagnostic Classification of Synucleinopathies

SHANGHAI, May 27, 2026 /PRNewswire/ — SynuSight Biotech (SynuSight), a clinical-stage biotech company focused on innovative pipeline development for neurodegenerative diseases, today announced the publication of a collaborative study in Cell with Professor Dan Li’s team at the Bio-X Institute of Shanghai Jiao Tong University. The study, titled "TPPP/p25 amyloid seeding activity as a specific […]

Read More
Travelport, Cognizant and Anthropic Collaborate to Power Travel Technology for the AI Era
Press Release

Travelport, Cognizant and Anthropic Collaborate to Power Travel Technology for the AI Era

Travelport, Cognizant and Anthropic are building an AI travel ecosystem to modernize how travel technology is built, tested and maintained Together they are closing the critical gap in AI-driven travel: connecting systems that can reason and plan with platforms that can actually transact TEANECK, N.J., May 27, 2026 /PRNewswire/ — Cognizant (NASDAQ: CTSH) is working […]

Read More
iQIYI's AI Platform Nadou Pro Surpasses 10,000 Creators, Unveils Advanced Feature Updates and Global Expansion
Press Release

iQIYI's AI Platform Nadou Pro Surpasses 10,000 Creators, Unveils Advanced Feature Updates and Global Expansion

BEIJING, May 27, 2026 /PRNewswire/ — On May 26th, iQIYI, China’s leading online entertainment platform, announced that Nadou Pro, its AI platform built for professional film and television production, has onboarded more than 10,000 active creators in under one month since opening for commercial use on April 20. In the same period, the platform has […]

Read More
Riverty Establishes Bank in Luxembourg
Press Release

Riverty Establishes Bank in Luxembourg

Fintech granted EU CRR banking licence after a 10-month application process Riverty transforms its Payment and Credit business from a PSD2 payment institution into a fully licensed bank Bank to begin operations in July, serving more than 1,800 merchants and approximately 25 million unique customers across 10 European markets Bertelsmann’s Carsten Coesfeld: "Banking license enables next […]

Read More
Club Med celebrates strong performance in 2025 and primed for 2026 expansion
Press Release

Club Med celebrates strong performance in 2025 and primed for 2026 expansion

HO CHI MINH CITY, Vietnam, May 27, 2026 /PRNewswire/ — Club Med, the global leader in premium all-inclusive holiday experiences, once again delivered strong performance in 2025 in an increasingly challenging macroeconomic and geopolitical environment. Consistent with the performance of the past two years, Club Med continues to deliver solid profitability and resilient growth with key […]

Read More
Deutsche Rück Group continues to grow profitably
Press Release

Deutsche Rück Group continues to grow profitably

DÜSSELDORF, Germany, May 27, 2026 /PRNewswire/ — The Deutsche Rück Group expanded its business in the 2025 financial year while at the same time strengthening its financial position. Gross written premiums grew once again across all strategic business segments, rising by 6.1% to more than €2.2 billion. Net premiums earned increased by 9.1% to around […]

Read More
Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV
Press Release

Brii Bio Presents Late-Breaking Data from Its Phase 2 ENSURE Study at EASL Congress 2026, Further Supporting the Potential Role of BRII-179 in Achieving Durable Immunological Control of HBV

– Final results from the ENSURE study demonstrate that the addition of elebsiran resulted in a higher functional cure rate compared with pegylated interferon alfa (PEG-IFNα) alone – Data from Cohort 4 suggested that participants responding to prior BRII‑179 treatment achieved the most robust functional cure outcomes, further supporting its potential clinical benefit – Data from an ENSURE […]

Read More

Sign In

Register

Reset Password

Please enter your username or email address, you will receive a link to create a new password via email.